| Oct 24 |
Best Momentum Stocks to Buy for October 24th
|
| Oct 21 |
Why Amicus Therapeutics (FOLD) is a Top Momentum Stock for the Long-Term
|
| Oct 18 |
Amicus: Teva Settlement Clears Revenue Path Forward For Galafold
|
| Oct 18 |
Can Amicus Therapeutics (FOLD) Run Higher on Rising Earnings Estimates?
|
| Oct 18 |
FOLD Stock Rises on Settling Galafold Patent Dispute With Teva
|
| Oct 18 |
Teva settles patent litigation with Amicus
|
| Oct 18 |
How Much Upside is Left in Amicus Therapeutics (FOLD)? Wall Street Analysts Think 43.44%
|
| Oct 18 |
Amicus Therapeutics (FOLD) Just Flashed Golden Cross Signal: Do You Buy?
|
| Oct 18 |
Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?
|
| Oct 17 |
Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
|
